Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2021

Jan 25, 2021

30722_dirs_2021-01-25_51877f29-62bd-4e73-a484-1ff385724c56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2020-10-01

Reporting Person: Neeleman Stephen (Director, Founder and Vice Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-01 Common Stock G 550 Disposed 575735 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 29884 Direct
Common Stock 203000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $41.28 2027-03-27 Common Stock (19897) 19897 Direct
Stock Option (right to buy) $61.72 2028-03-27 Common Stock (14228) 14228 Direct
Stock Option (right to buy) $14 2024-07-30 Common Stock (140000) 140000 Direct
Stock Option (right to buy) $73.61 2029-03-26 Common Stock (15337) 15337 Direct

Footnotes

F1: Shares held of record by the Stephen and Christine Neeleman Trust.

F2: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

F3: The option is exercisable as to 14,992 shares. The option becomes exercisable as to the remaining 4,975 options on March 27, 2021.

F4: The option is exercisable as to 7,114 shares. The remaining options become exercisable in two equal installments of 3,557 options on March 27, 2021, and 2022.

F5: The option is immediately exercisable.

F6: The option is exercisable as to 3,835 shares. The remaining options vest as to 3,384 shares on each of March 27, 2021, 2022 and 2023.